Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024;6(1):21-32.
doi: 10.46439/toxicology.6.029.

Non-alcoholic fatty liver disease: Role of PNPLA3 and its association with environmental chemicals

Affiliations

Non-alcoholic fatty liver disease: Role of PNPLA3 and its association with environmental chemicals

Shakil A Saghir et al. Arch Clin Toxicol (Middlet). 2024.

Abstract

Globally, non-alcoholic fatty liver disease (NAFLD) is on the rise with 30-32%, 27-33%, 35-48%, 36%, 9-20%, and 36-38% prevalence in Asia, Europe, North America, South America, Africa, and Australia, respectively. Approximately, 5-10% of NAFLD proceeds to hepatitis called non-alcoholic steatohepatitis (NASH). NASH often progresses to liver fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). Precise mechanism(s) for the development of HCC is not fully understood in NAFLD and NASH patients. Higher insulin levels in type 2 diabetes (T2D) can result in lipolysis of adipose tissue activating lipid synthesizing enzymes such as fatty acid synthase and stearoyl-CoA desaturase-1, resulting in lipid accumulation in liver. Higher levels of glucose in T2D patients activate carbohydrate response element binding protein and insulin which increases the level of active sterol regulatory element binding protein. These lipogenic transcription factors activate patatin-like phospholipase domain-containing protein-3 (PNPLA3) from their response elements in the promoter. Endocrine disrupting chemicals (EDCs) and persistent organic pollutants (POPs) are implicated in T2D development and NAFLD. The emerging association between POPs, including insecticides, fungicides, herbicides, and diabetes has been noted. However, their connection with NAFLD remains less evident. Here, we reviewed association of POPs, especially EDCs, and role of PNPLA3 in the development of NAFLD and NASH. We also reviewed the role of single nucleotide polymorphisms of PNPLA3's association with NAFLD.

Keywords: Hepatocellular carcinoma; Liver fibrosis; Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Patatin-like phospholipase domain-containing protein 3.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
The conditions and transformation of normal liver to NAFLD, and NASH.
Figure 2.
Figure 2.
Regulation of the PNPLA3 gene by carbohydrate-response element binding protein (ChREBP) and sterol regulatory element binding protein-1c (SREBP-1c).

References

    1. Paschos P, Paletas K. Non alcoholic fatty liver disease and metabolic syndrome. Hippokratia. 2009. Jan;13(1):9–19. - PMC - PubMed
    1. Teng ML, Ng CH, Huang DQ, Chan KE, Tan DJ, Lim WH, et al. Global incidence and prevalence of nonalcoholic fatty liver disease. Clinical and Molecular Hepatology. 2023. Feb;29(Suppl):S32–42. - PMC - PubMed
    1. Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nature Reviews Gastroenterology & Hepatology. 2018. Jan;15(1):11–20. - PubMed
    1. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease—meta- analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016. Jul 1;64(1):73–84. - PubMed
    1. Idalsoaga F, Kulkarni AV, Mousa OY, Arrese M, Arab JP. Non-alcoholic fatty liver disease and alcohol-related liver disease: two intertwined entities. Frontiers in Medicine. 2020. Aug 20;7:448. - PMC - PubMed

LinkOut - more resources